SCHEMBL4907309

SCHEMBL4907309

O=C1N=Nc2ccccc21.O=c1c(O)c(O)c1=O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APAF1 O14727 2/20 0.37
TDP2 O95551 1/20 0.37
HDAC4 P56524 1/20 0.35
HDAC2 Q92769 1/20 0.35
HDAC8 Q9BY41 1/20 0.35
HDAC6 Q9UBN7 1/20 0.35
ALDH1A1 P00352 7/20 0.35
MAPT P10636 7/20 0.35
KMT2A Q03164 6/20 0.35
MEN1 O00255 5/20 0.35
KDM4E B2RXH2 4/20 0.35
L3MBTL1 Q9Y468 3/20 0.35
TSHR P16473 2/20 0.35
LMNA P02545 1/20 0.35
HSP90AA1 P07900 1/20 0.35
HSP90AB1 P08238 1/20 0.35
HK1 P19367 1/20 0.35
GALK1 P51570 1/20 0.35
HKDC1 Q2TB90 1/20 0.35
AHR P35869 4/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL94097 0.87 MEN1 (0.41) APAF1TDP2ALDH1A1MAPTKMT2A
Hexane SCHEMBL28514659 0.74 PTPN1 (0.40) ALDH1A1MAPTKMT2AMEN1SMN1; SMN2
SCHEMBL2996853 0.74 MEN1 (0.43) APAF1TDP2ALDH1A1MAPTKMT2A
SCHEMBL29714477 0.72 MEN1 (0.50) APAF1TDP2ALDH1A1MAPTKMT2A
SCHEMBL112133 0.72 MEN1 (0.50) APAF1TDP2ALDH1A1MAPTKMT2A
SCHEMBL1248614 0.71 TDO2 (0.31) CA9
SCHEMBL30218501 0.70 MEN1 (0.47) APAF1TDP2ALDH1A1MAPTKMT2A
SCHEMBL26128819 0.70 MEN1 (0.47) APAF1TDP2ALDH1A1MAPTKMT2A
SCHEMBL3289725 0.69 AHR (0.40) APAF1TDP2ALDH1A1MAPTKMT2A
SCHEMBL472878 0.68 MEN1 (0.36) APAF1TDP2ALDH1A1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080234348-A1 3-Oxoindazolesquaric Acid Derivatives MERCK PATENT GESELLSCHAFT (DE) 2008-09-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080234348-A1 3-Oxoindazolesquaric Acid Derivatives CHEK2, CHEK1, SGK2 APAF1 3915/4885TDP2 1786/4885HDAC4 1420/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.